Aurobindo Pharma receives USFDA approval for Modafinil Tablets

28 Sep 2012 Evaluate

Aurobindo Pharma has received an approval from the US Food and Drug Administration (USFDA) to manufacture and market Modafinil Tablets USP 100mg and 200mg (ANDA 202566). The product is ready for launch. The product has been approved out of Unit VII (SEZ) formulations facility in Hyderabad, India.

Modafinil Tablets are the generic equivalent of Cephalon, Inc’s Provigil Tablets. Modafinil Tablets USP 100mg and 200mg are indicated in adults for treatment of narcolepsy, shift work sleep disorders and excessive daytime sleepiness associated with obstructive sleep apnea. According to IMS for the twelve months ending March 2012, the product has a market size of approximately $1.2 billion.

Aurobindo now has a total of 160 ANDA approvals (135 Final approvals including 1 from Aurolife Pharma LLC and 25 Tentative approvals) from USFDA.

Aurobindo Pharma Share Price

1240.70 -14.70 (-1.17%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.